SHG:688273 - Nanjing Medlander Medical Technology Co Ltd

Nanjing Medlander Medical Tech
Sector: Health Care, Industry: Health Care Equipment

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2018 Q4	2019 Q4	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	32.3% -13.7%	34.65% 7.3%	33.51% -3.3%	29.61% -11.7%	33.93% 14.6%	32.35% -4.7%	32.38% 0.1%	33.68% 4.0%	29.42% -12.6%	26.35% -10.4%	27.89% 5.8%	28.39% 1.8%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	73.1% 0.7%	72.93% -0.2%	72.31% -0.8%	67.4% -6.8%	68.36% 1.4%	68.55% 0.3%	66.28% -3.3%	71.06% 7.2%	71.41% 0.5%	71.11% -0.4%	74.62% 4.9%	73.86% -1.0%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	37.03% -15.8%	36.6% -1.1%	35.42% -3.2%	31.31% -11.6%	36.41% 16.3%	35.08% -3.7%	33.75% -3.8%	32.95% -2.4%	25.97% -21.2%	21.84% -15.9%	24.34% 11.4%	27.28% 12.1%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	335.33M 258.6%	341.64M 1.9%	355.62M 4.1%	370.67M 4.2%	409.35M 10.4%	376.89M -7.9%	411.44M 9.2%	398.16M -3.2%	369.03M -7.3%	340.82M -7.6%	336.04M -1.4%	364.81M 8.6%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	425.7M 2.4%	488.74M 14.8%	521.88M 6.8%	564.16M 8.1%	1.52B 169.1%	1.51B -0.4%	1.51B -0.2%	1.49B -1.2%	1.5B 0.6%	1.53B 2.2%	1.55B 1.3%	1.54B -1.0%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	95.6M -12.8%	116.01M 21.4%	122.27M 5.4%	134.35M 9.9%	110.76M -17.6%	141.96M 28.2%	101.52M -28.5%	119.04M 17.3%	104.23M -12.4%	158.6M 52.2%	148.42M -6.4%	156.77M 5.6%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	363.5M -	386.01M 6.2%	412.97M 7.0%	1.39B 235.9%	1.35B -2.7%	1.39B 2.7%	1.34B -3.2%	1.37B 1.9%	1.35B -1.6%	1.37B 1.8%	1.35B -1.8%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	148.6M -	125.54M -15.5%	26.17M -79.2%	-	126.67M -	-	155.56M -	-	136.91M -	-	127.93M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	215.63M 334.7%	149.82M -30.5%	49.61M -66.9%	215.63M 334.7%	44.19M -79.5%	272.12M 515.8%	158.33M -41.8%	136.75M -13.6%	1.04B 663.9%	1.18B 12.6%	852.59M -27.5%	889.87M 4.4%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	44.19M -79.5%	272.12M 515.8%	157.83M -42.0%	136.75M -13.4%	1.04B 663.8%	1.18B 12.6%	853.09M -27.4%	889.84M 4.3%	604.25M -32.1%	991.63M 64.1%	986.72M -0.5%	907.62M -8.0%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	100.12M 61.5%	134.01M 33.9%	104.3M -22.2%	70.8M -32.1%	97.82M 38.2%	72.41M -26.0%	106.2M 46.7%	83.33M -21.5%	59.4M -28.7%	61.76M 4.0%	-507.59K -	32.38M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	119.7M -	122.35M 2.2%	51.35M -58.0%	-	129.53M -	-	138.84M -	-	92.48M -	-	107.73M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.444 209.6%	1.578 9.3%	1.589 0.7%	1.463 -7.9%	1.805 23.4%	1.463 -18.9%	1.506 2.9%	1.427 -5.2%	1.046 -26.7%	0.898 -14.2%	0.94 4.7%	1.045 11.1%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	33.59% 186.4%	39.2% 16.7%	30.88% -21.2%	30.86% -0.1%	16.25% -47.3%	14.23% -12.5%	15.03% 5.6%	15.28% 1.7%	7.88% -48.4%	6.66% -15.5%	6.8% 2.0%	7.71% 13.4%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	25.45% 202.2%	28.78% 13.1%	22.84% -20.6%	22.4% -1.9%	14.29% -36.2%	12.2% -14.7%	13.12% 7.6%	13.05% -0.6%	7.19% -44.9%	5.9% -18.0%	6.12% 3.7%	6.84% 11.7%